Abstract
The invention relates to a Cas9 expression plasmid. The Cas9 expression plasmid includes a tracrRNA sequence, aCas9gene and a chloramphenicol resistance gene. The Cas9 expression plasmid can be used in CRISPR/Cas9-coupled lambda red recombineering for efficiently editing genomes ofEscherichia coli.